Health
COVID-19 vaccine study has a warning for people who take common IBD drug – SlashGear
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower…
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower than expected. The issue was observed in people taking an immune-suppressing drug called infliximab, which is commonly prescribed for IBD.
Vaccines, including the COVID-19 vaccine, work by triggering the patient’s own immune system, resulting in the development of antibodies that help protect the individual from an infection caused by…
-
Noosa News19 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News17 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General22 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News21 hours agoStar Entertainment faces $36.5m blow if Queen’s Wharf deal flops